1 |
34714908 |
10.1182/bloodadvances.2021005486 |
2022 |
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. |
NFKB2 |
2 |
36009586 |
10.3390/biomedicines10082038 |
2022 |
Genomic Aberrations Generate Fusion Gene FOXK2::TP63 and Activate NFKB1 in Cutaneous T-Cell Lymphoma. |
NFKB2 |
3 |
33184494 |
10.1038/s41375-020-01088-y |
2021 |
A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma. |
NFKB2 |
4 |
31586084 |
10.1038/s41598-019-50528-y |
2020 |
Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients. |
NFKB2 |
5 |
32350066 |
10.1158/0008-5472.CAN-19-2247 |
2020 |
FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells. |
NFKB2 |
6 |
29973688 |
10.1038/s41388-018-0363-4 |
2019 |
Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3. |
NFKB2 |
7 |
30401751 |
10.1182/bloodadvances.2018022962 |
2019 |
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia. |
NFKB2 |
8 |
30857150 |
10.3390/ijms20051182 |
2019 |
Temporal Splicing Switches in Elements of the TNF-Pathway Identified by Computational Analysis of Transcriptome Data for Human Cell Lines. |
NFKB2 |
9 |
29693141 |
10.3892/mmr.2018.8911 |
2018 |
Analysis of NFKB2‑mediated regulation of mechanisms underlying the development of Hodgkin's lymphoma. |
NFKB2 |
10 |
25912249 |
10.4274/tjh.2014.0190 |
2017 |
Deregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period. |
NFKB2 |
11 |
27039262 |
10.1016/j.jid.2016.03.024 |
2017 |
Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome. |
NFKB2 |
12 |
28368397 |
10.1038/onc.2017.90 |
2017 |
Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype. |
NFKB2 |
13 |
28689659 |
10.1016/j.molcel.2017.06.011 |
2017 |
Bcl3 Phosphorylation by Akt, Erk2, and IKK Is Required for Its Transcriptional Activity. |
NFKB2 |
14 |
26455434 |
10.1038/ncomms9428 |
2016 |
Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth. |
NFKB2 |
15 |
26556860 |
10.18632/oncotarget.5715 |
2016 |
The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia. |
NFKB2 |
16 |
25873174 |
10.1016/j.ccell.2015.03.006 |
2015 |
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. |
NFKB2 |
17 |
25873381 |
10.1128/mBio.00441-15 |
2015 |
Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3. |
NFKB2 |
18 |
26112410 |
10.1074/jbc.M114.630061 |
2015 |
The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100. |
NFKB2 |
19 |
21787835 |
10.1016/j.mce.2011.07.021 |
2012 |
Inhibition of Bcl3 gene expression mediates the anti-proliferative action of estrogen in pituitary lactotrophs in primary culture. |
NFKB2 |
20 |
21871426 |
10.1016/j.ajpath.2011.07.003 |
2012 |
p52 Activation in monomorphic B-cell posttransplant lymphoproliferative disorder/diffuse large B-cell lymphoma without BAFF-R expression. |
NFKB2 |
21 |
22083306 |
10.1007/s10059-011-0177-5 |
2012 |
Nuclear factor-κB2 represses Sp1-mediated transcription at the CD99 promoter. |
NFKB2 |
22 |
22624040 |
10.1371/journal.pone.0037498 |
2012 |
A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma. |
NFKB2 |
23 |
22642622 |
10.1186/1471-2407-12-203 |
2012 |
NF-κB2 mutation targets survival, proliferation and differentiation pathways in the pathogenesis of plasma cell tumors. |
NFKB2 |
24 |
21228035 |
10.3324/haematol.2010.030577 |
2011 |
Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens. |
NFKB2 |
25 |
19773279 |
10.1136/oem.2008.044024 |
2010 |
Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. |
NFKB2 |
26 |
20558726 |
10.1074/jbc.M110.112128 |
2010 |
BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1. |
NFKB2 |
27 |
20598117 |
10.1186/1471-2407-10-348 |
2010 |
Myc suppression of Nfkb2 accelerates lymphomagenesis. |
NFKB2 |
28 |
20800578 |
10.1016/j.bbrc.2010.08.084 |
2010 |
Bcl3-dependent stabilization of CtBP1 is crucial for the inhibition of apoptosis and tumor progression in breast cancer. |
NFKB2 |
29 |
19219072 |
10.1038/onc.2009.6 |
2009 |
Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes. |
NFKB2 |
30 |
19573080 |
10.1111/j.1365-2141.2009.07790.x |
2009 |
Common genetic variants in candidate genes and risk of familial lymphoid malignancies. |
NFKB2 |
31 |
17573907 |
10.1111/j.1462-5822.2007.00950.x |
2008 |
Alteration of NF-kappaB activity leads to mitochondrial apoptosis after infection with pathological prion protein. |
NFKB2 |
32 |
18025803 |
10.1159/000111116 |
2008 |
Expression of nuclear factor-kappaB family proteins in hepatocellular carcinomas. |
NFKB2 |
33 |
18367492 |
10.3324/haematol.12221 |
2008 |
Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia. |
NFKB2 |
34 |
18377428 |
10.1111/j.1349-7006.2008.00750.x |
2008 |
Rearranged NF-kappa B2 gene in an adult T-cell leukemia cell line. |
NFKB2 |
35 |
17134739 |
10.1016/j.humpath.2006.08.023 |
2007 |
Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones. |
NFKB2 |
36 |
17356384 |
10.1097/01.jnen.0000248553.45456.96 |
2007 |
Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression. |
NFKB2 |
37 |
17476277 |
10.1038/sj.leu.2404723 |
2007 |
Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells. |
NFKB2 |
38 |
16490595 |
10.1016/j.cancergencyto.2005.08.008 |
2006 |
Translocation (5;10)(q22;q24) in a case of acute lymphoblastic leukemia. |
NFKB2 |
39 |
16751281 |
10.1073/pnas.0507809103 |
2006 |
The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas. |
NFKB2 |
40 |
16940298 |
10.1074/jbc.M603194200 |
2006 |
Up-regulation of cyclin D1 by HBx is mediated by NF-kappaB2/BCL3 complex through kappaB site of cyclin D1 promoter. |
NFKB2 |
41 |
15384172 |
10.1002/gcc.20104 |
2005 |
A microarray model system identifies potential new target genes of the proto-oncogene HOX11. |
NFKB2 |
42 |
15782119 |
10.1038/sj.onc.1208564 |
2005 |
Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts. |
NFKB2 |
43 |
16108830 |
10.1111/j.1349-7006.2005.00078.x |
2005 |
Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3. |
NFKB2 |
44 |
14678988 |
|
2004 |
Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. |
NFKB2 |
45 |
15469820 |
10.1016/j.molcel.2004.09.004 |
2004 |
GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. |
NFKB2 |
46 |
12808109 |
10.1128/MCB.23.13.4713-4727.2003 |
2003 |
p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1. |
NFKB2 |
47 |
12835724 |
10.1038/sj.leu.2402982 |
2003 |
NF- kappa B2/p100 induces Bcl-2 expression. |
NFKB2 |
48 |
12894228 |
10.1038/sj.onc.1206761 |
2003 |
Regulation of NF-kappaB2/p100 processing by its nuclear shuttling. |
NFKB2 |
49 |
14576817 |
10.1038/sj.onc.1207120 |
2003 |
Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway. |
NFKB2 |
50 |
11707390 |
10.1093/emboj/20.22.6180 |
2002 |
Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family. |
NFKB2 |
51 |
10713675 |
10.1038/sj.onc.1203432 |
2000 |
Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes. |
NFKB2 |
52 |
10830747 |
10.3109/10428190009087031 |
2000 |
Normal structure of NFKB2, C-REL and BCL-3 gene loci in lymphoproliferative and myeloproliferative disorders. |
NFKB2 |
53 |
9407099 |
10.1074/jbc.272.52.33132 |
1998 |
Diverse effects of BCL3 phosphorylation on its modulation of NF-kappaB p52 homodimer binding to DNA. |
NFKB2 |
54 |
9021684 |
10.3109/10428199609054800 |
1997 |
The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies. |
NFKB2 |
55 |
9264393 |
10.1038/sj.leu.2400778 |
1997 |
Germline configuration of nfkb2, c-rel and bcl3 in childhood acute lymphoblastic leukemia (ALL). |
NFKB2 |
56 |
7579411 |
|
1995 |
Molecular analysis of cutaneous B- and T-cell lymphomas. |
NFKB2 |
57 |
7597296 |
10.1007/978-3-642-78771-3_19 |
1995 |
bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas. |
NFKB2 |
58 |
7949142 |
|
1994 |
Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies. |
NFKB2 |
59 |
8036016 |
|
1994 |
Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells. |
NFKB2 |
60 |
8108136 |
|
1994 |
Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10. |
NFKB2 |
61 |
8113688 |
10.1084/jem.179.3.961 |
1994 |
The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. |
NFKB2 |
62 |
8208540 |
|
1994 |
Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions. |
NFKB2 |
63 |
7692229 |
10.1128/mcb.13.10.6283-6289.1993 |
1993 |
Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-kappa B subunits in endothelial and epithelial cells. |
NFKB2 |
64 |
8378093 |
|
1993 |
Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies. |
NFKB2 |
65 |
8453667 |
10.1016/0092-8674(93)90401-b |
1993 |
The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. |
NFKB2 |
66 |
1612589 |
10.1016/0888-7543(92)90244-m |
1992 |
Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2. |
NFKB2 |
67 |
1760839 |
10.1016/0092-8674(91)90285-7 |
1992 |
B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. |
NFKB2 |